Italy Peptide Receptor Radionuclide Therapy (PRRT) Market Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027
Italy Peptide Receptor Radionuclide Therapy (PRRT) Market
Due to low competition and rising
demand for peptide receptor radionuclide therapy in the Italian industry, there
are several potential for important players to enter this market. Additionally,
the need for PRRT therapy is directly impacted by Italy's rising cancer
incidence. These elements are giving businesses the chance to expand by putting
their attention on the study and creation of new medications. According to a
research by the Italian Association of Medical Oncology, 71,000 new cases of
cancer were detected in April 2019.
The Italy peptide receptor radionuclide therapy market
could be significantly impacted by side effects related to this treatment. The
radiation-treated body component experiences the side effects. Patients
receiving radiation therapy frequently experience nausea, vomiting, abdominal
pain, and in certain circumstances, transient hair loss and subacute
haematological poisoning. Therefore, this might prevent the growth of the
Italian market for peptide receptor radionuclide therapy.
Over the course of the projected
period, rising pancreatic cancer incidence in the Europe region is anticipated
to promote market expansion. For instance, the number of instances of
pancreatic cancer increased by 5% in the Europe region between 1990 and 2016,
according to a report from United European Gastroenterology.
Comments
Post a Comment